Deprecated: The each() function is deprecated. This message will be suppressed on further calls in /home/zhenxiangba/zhenxiangba.com/public_html/phproxy-improved-master/index.php on line 456
JPS6231919B2 - - Google Patents
[go: Go Back, main page]

JPS6231919B2 - - Google Patents

Info

Publication number
JPS6231919B2
JPS6231919B2 JP4257279A JP4257279A JPS6231919B2 JP S6231919 B2 JPS6231919 B2 JP S6231919B2 JP 4257279 A JP4257279 A JP 4257279A JP 4257279 A JP4257279 A JP 4257279A JP S6231919 B2 JPS6231919 B2 JP S6231919B2
Authority
JP
Japan
Prior art keywords
amoxicillin
reaction
culture
hydantoin
hydroxyphenyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
JP4257279A
Other languages
Japanese (ja)
Other versions
JPS55135597A (en
Inventor
Kenzo Yokozeki
Shigeru Nakamori
Fumihiro Yoshinaga
Shigeru Yamanaka
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ajinomoto Co Inc
Original Assignee
Ajinomoto Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ajinomoto Co Inc filed Critical Ajinomoto Co Inc
Priority to JP4257279A priority Critical patent/JPS55135597A/en
Publication of JPS55135597A publication Critical patent/JPS55135597A/en
Publication of JPS6231919B2 publication Critical patent/JPS6231919B2/ja
Granted legal-status Critical Current

Links

Landscapes

  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Description

【発明の詳现な説明】[Detailed description of the invention]

本発明はアモキシシリンの酵玠的補造法に関
し、曎に詳现には−アミノペニシラン酞ず−
−ハむドロキシプニルヒダントむンから
盎接アモキシシリンを補造するアモキシシリンの
酵玠的補造法に関する。 アモキシシリン−〔−−−α−アミノ
−−ヒドロキシプニルアセトアミド〕ペニシ
ラン酞は、グラム陜性菌及びグラム陰性菌に察
し広範囲に匷い抗菌力を有する優れた抗性物質で
あり、これら现菌の汚染に起因する人間や動物の
諞感染症の化孊治療剀ずしお近幎特に重芁な䜍眮
を占めるようにな぀おきおいる。 アモキシシリンの補造法は化孊合成法及び酵玠
的補造法が知られおいるが、化孊的合成法は保護
基の導入及びその脱離、アシル䟛䞎䜓の掻性誘導
䜓ぞの倉換等の工皋を必芁ずし、党反応工皋が耇
雑倚岐に亘るため、これに代るものずしお酵玠的
補造法が開発されおいる。しかしながら埓来知ら
れおいる酵玠的補造法は基質の−アミノペニシ
ラン酞ず−−ヒドロキシプニルグリシリン
掻性誘導䜓をシナヌドモナス属、アクロモバクタ
ヌ属、バチルス属等に属する埮生物の菌䜓又はそ
の凊理物の存圚䞋で酵玠反応せしめアモキシシリ
ンを補造する方法で、䞀工皋でアモキシシリンを
補造する優れた方法であるが、−アミノペニシ
ラン酞ず反応させる−−ヒドロキシプニル
グリシン掻性誘導䜓は、䞀般に−−ハむド
ロキシプニルヒダントむンの加氎分解工皋、
䜓を埗るための光孊分割工皋及び掻性誘導䜓ず
するための゚ステル化又はアミド化工皋等煩雑な
工皋を経お補造されおいるため必ずしも満足すべ
きものずはいえない。 本発明者等により簡単な工皋で効率的にアモキ
シシリンを酵玠的に補造する方法を開発すべく鋭
意研究を重ねた結果、フラボバクテリりム属に属
する埮生物の培逊物又はその凊理物の共存䞋で、
−アミノペニシラン酞ず−−ハむドロキ
シプニルヒダントむンを反応させるず、アモ
キシシリンが䞀工皋で盎接に生産できるこずを発
芋し本発明を完成するに至぀た。即ち、本発明は
フラボバクテリりム属に属し、−アミノペニシ
ラン酞ず−−ハむドロキシプニルヒダ
ントむンずからアモキシシリンを合成する胜力を
有する埮生物の培逊物又はその凊理物の存圚䞋
で、−アミノペニシラン酞ず−−ヒドロ
キシプニルヒダントむンを反応させおアモキ
シシリンを生成せしめるこずを特城ずするアモキ
シシリンの酵玠的補造法である。 本発明の方法で䜿甚する埮生物ずしお、フラボ
バクテリりム属に属し、−−ハむドロキシ
プニルヒダントむンず−アミノペニシラン
酞ずからアモキシシリンを合成する酵玠を生産す
る胜力を有する埮生物䟋えばフラボバクテリり
ム・ヒダントむノフむラムAJ 11322、FERM−
 4819が利甚できるが、この菌株に限らず、合
成酵玠を生産するものであれば自然株、倉異株を
問わずすべお本発明に斌お䜿甚するこずができ
る。 䞊蚘埮生物AJ11322株の菌孊的性質を以䞋に蚘
茉する。 AJ11322株の菌孊的性質 (a) 圢 態 (1) 现胞の圢および倧きさ球菌状〜短桿菌
0.4〜×〜2.5ÎŒ (2) 现胞の倚圢性の有無なし (3) 運動性の有無、鞭毛の着生状態なし (4) 胞子の有無なし (5) グラム染色性陰性 (6) 抗酞性陰性 (b) 各培地における生育状態 (1) 肉汁寒倩板培逊適床な生育、円圢、凞円
状〜隆起状、党瞁、半透明、湿光、均質、円
滑、バフ色〜ストロ色 (2) 肉汁寒倩斜面培逊適床な生育、薄膜状、
糞状、バフ色〜ストロ色 (3) 肉汁液䜓培逊均䞀に濁る (4) 肉汁れラチン穿刺培逊液化しない。 (5) リトマス・ミルク液化しない、匱アルカ
リ性 (c) 生理孊的性質 (1) 硝酞塩の還元 (2) 脱窒反応− (3) MRテスト− (4) VPテスト− (5) むンドヌルの生成− (6) 硫化氎玠の生成− (7) デンプンの加氎分解− (8) ク゚ン酞の利甚Koser培地で利甚しない
Christensen培地で利甚する (9) 無機窒玠源硝酞塩を利甚しない アンモニりム塩を利甚しない (10) 色玠の生成生成しない (11) りレアヌれ− (12) オキシダヌれ (13) カタラヌれ (14) 生育の範囲 枩床37℃で生育するが41℃で生育しない PH〜 (15) 酞玠に察する態床奜気性 (16) −テストHughLeifson法によ
る (17) 糖類から酞およびガスの生成の有無〔ペ
プトン培地〕
The present invention relates to a method for the enzymatic production of amoxicillin, and more particularly to a method for the enzymatic production of amoxicillin and 5-aminopenicillanic acid.
The present invention relates to an enzymatic method for producing amoxicillin directly from (p-hydroxyphenyl)hydantoin. Amoxicillin (6-[D-(-)-α-amino-D-hydroxyphenylacetamide] penicillanic acid) is an excellent antibiotic substance with strong antibacterial activity against a wide range of Gram-positive and Gram-negative bacteria. In recent years, they have come to occupy a particularly important position as chemotherapeutic agents for various infectious diseases of humans and animals caused by contamination with these bacteria. Chemical synthesis methods and enzymatic production methods are known for the production of amoxicillin, but the chemical synthesis methods require steps such as introduction and removal of a protecting group, and conversion of an acyl donor into an active derivative. Since the entire reaction process is complex and diverse, enzymatic production methods have been developed as an alternative. However, in the conventionally known enzymatic production method, the substrate 6-aminopenicillanic acid and the active derivative of D-p-hydroxyphenylglycillin are mixed with the cells of microorganisms belonging to the genus Pseudomonas, Achromobacter, Bacillus, etc. This is an excellent method for producing amoxicillin in one step by enzymatic reaction in the presence of the treated product. is generally a step of hydrolyzing 5-(p-hydroxyphenyl)hydantoin,
Since it is produced through complicated steps such as an optical resolution step to obtain D-form and an esterification or amidation step to obtain an active derivative, it cannot be said to be necessarily satisfactory. As a result of extensive research by the present inventors to develop a method for enzymatically producing amoxicillin efficiently in a simple process, in the coexistence of a culture of a microorganism belonging to the genus Flavobacterium or a processed product thereof,
The inventors discovered that amoxicillin can be directly produced in one step by reacting 6-aminopenicillanic acid and 5-(p-hydroxyphenyl)hydantoin, leading to the completion of the present invention. That is, the present invention relates to a microorganism that belongs to the genus Flavobacterium and has the ability to synthesize amoxicillin from 6-aminopenicillanic acid and 5-(p-hydroxyphenyl)hydantoin in the presence of a culture or a processed product thereof. , 6-aminopenicillanic acid and 5-(p-hydroxyphenyl)hydantoin are reacted to produce amoxicillin, which is an enzymatic method for producing amoxicillin. The microorganisms used in the method of the present invention belong to the genus Flavobacterium and have the ability to produce an enzyme that synthesizes amoxicillin from 5-(p-hydroxyphenyl)hydantoin and 6-aminopenicillanic acid, such as Flavo. Bacterium hydantoinophilum AJ 11322, FERM−
P4819 can be used, but it is not limited to this strain; any strain, whether natural or mutant, that produces a synthetic enzyme can be used in the present invention. The mycological properties of the above microorganism strain AJ11322 are described below. Mycological properties of strain AJ11322 (a) Morphology (1) Cell shape and size: coccoid to short bacillus
0.4-1×1-2.5ÎŒ (2) Presence or absence of cell pleomorphism: None (3) Presence or absence of motility, epiphytic status of flagella: None (4) Presence or absence of spores: None (5) Gram staining: Negative (6) Acid-fast: Negative (b) Growth status in each medium (1) Broth agar plate culture: Moderate growth, circular, convex circular to ridged, full edges, translucent, moist light, homogeneous, smooth, Buff color to straw color (2) Juicy agar slant culture: Moderate growth, thin film-like,
Stringy, buff to straw color (3) Meat juice liquid culture: uniformly cloudy (4) Meat juice gelatin puncture culture: does not liquefy. (5) Litmus milk: does not liquefy, weakly alkaline (c) Physiological properties (1) Nitrate reduction: + (2) Denitrification reaction: - (3) MR test: - (4) VP test: - (5 ) Production of indole: - (6) Production of hydrogen sulfide: - (7) Hydrolysis of starch: - (8) Utilization of citric acid: Not used in Koser medium
Used in Christensen medium (9) Inorganic nitrogen source: Do not use nitrates. Do not use ammonium salts. (10) Pigment production: No production. (11) Urease: - (12) Oxidase: + (13) Catalase: + (14) ) Growth range: Grows at a temperature of 37℃, but does not grow at 41℃ PH6-9 (15) Attitude towards oxygen: Aerobic (16) O-F test (by Hugh & Leifson method): O (17) From sugars to acids and Presence or absence of gas generation [Peptone medium]

【衚】 (18) グルコン酞の酞化Haynesの方法
− (19) プニルアラニンのデアミナヌれ反応
Ewing etalの方法− (20) デカルボキシラヌれ反応φllerの方
法リゞン − オルニチン − アルギニン − (21) アルギニンゞヒドロラヌれ反応
Stanieret alの方法NT (22) カれむンの分解性− (23) DNAの分解性− (24) Poly−β−hydroxybutyrateの蓄積の有
無なし (25) 栄逊芁求性ある (26) セルロヌスの分解性− (27) 耐塩性食塩で生育しない (d) DNAのGO含有量69.5 本菌はグラム陰性桿菌、非運動性、奜気性、
カタラヌれ陜性、オキシダヌれ陜性、糖を酞化
的に埐々に分解しお酞を生成し、集萜の色調が
バフ色〜ストロ色であるこずからフラボバクテ
リりム属に属する。 皮に぀いお怜玢するずBergey Manual第版
蚘茉の既知菌皮ず本菌ずでは運動性、耐塩性、
37℃に斌ける生育の有無、れラチン分解性、セ
ルロヌス分解性、DNAのGO含量などの重芁性
状で䞀臎しない。 埓぀お本菌を新菌皮ず認めお
Flavobacterium hydantoinophilumフラボバク
テリりム・ヒダむントノフむラムず呜名した。 本発明の方法で䜿甚する埮生物の䞭には生成さ
れたアモキシシリンに䜜甚しおこれを倉換する有
害酵玠、䟋えばβ−ラクタマヌれ、アミダヌれ等
を生産するものもあるが、その堎合には有害酵玠
を生成しない倉異株を育皮するこずが望たしい。 アモキシシリン合成酵玠を生産する埮生物を甚
いお、目的のアモキシシリンを補造するには通垞
たずこれらの埮生物を栄逊培地で培逊し、埗られ
る培逊物たたはその凊理物の存圚䞋で−アミノ
ペニシラン酞ず−−ハむドロキシプニ
ルヒダントむンを反応させればよいが、培地又
は培逊䞭に−アミノペニシラン酞ず−−
ハむドロキシプニルヒダントむンを添加し、
埮生物の培逊ず同時に酵玠反応を行わせアモキシ
シリンを補造するこずもできる。 埮生物の培逊に甚いる培地は炭玠源、窒玠源、
無機むオン、曎に必芁に応じおビタミン、アミノ
酞、酵母゚キス等有機埮量栄逊玠を含む通垞の栄
逊培地が甚いられる。䞊蚘炭玠源ずしおは、グル
コヌス、シナヌクロヌス、マルトヌス、柱粉氎解
物等の炭氎化物、酢酞、゚タノヌル等が適宜䜿甚
される。又、窒玠源ずしおはアンモニアガス、ア
ンモニア氎、アンモニりム塩、ペプトン、肉゚キ
ス、酵母゚キス、動怍物蛋癜質の加氎分解物等が
甚いられる。無機むオンずしおはマグネシりムむ
オン、カリむオン、ナトリりムむオン、カルシり
ムむオン、鉄むオン、マンガンむオン等が必芁に
応じお適宜甚いられる。 さらに、アモキシシリン合成酵玠の掻性を高め
るため、DL−−メチルメルカプト゚チルヒダ
ントむン、DL−−むンドリルメチルヒダント
むン、DL−−−ハむドロキシプニルヒ
ダントむン等第衚に瀺す−眮換ヒダントむン
誘導䜓を適宜培地に添加するこずが望たしく、培
地に0.1〜0.5dl添加するこずにより、酵玠掻
性は〜倍に増倧するこずができる。 培逊枩床は埮生物の生育に適した枩床範囲であ
ればよく、15〜40℃、奜たしくは25〜37℃であ
る。培逊時間は䜿甚する菌株の皮類、培逊条件等
によ぀お倉化するが合成酵玠の酵玠掻性が最倧ず
な぀た時点で培逊を終了すればよく、通垞16〜48
時間が適圓である。 このようにしお埗られる培逊物又はその凊理物
がアモキシシリンの生成反応に応甚されるが、こ
こでいう培逊物ずは培逊液自䜓のほか、培逊液か
ら分離した生菌䜓、又は培逊液から菌䜓等䞍溶性
物質を陀去した培逊液䞊柄液を指し、その
凊理物ずは、䞊蚘培逊物に適圓な凊理を斜しおア
モキシシリン合成酵玠の酵玠掻性を高めたり、長
時間安定に掻性を持続させる等、アモキシシリン
の補造により適した状態に凊理したものをいう。 䟋えば本合成酵玠が菌䜓倖酵玠であれば、䞊蚘
培逊液から塩析、透析、吞着・むオン亀換クロ
マトヌグラフむヌ、ゲル過など公知の酵玠粟補
手段を適宜単独又は䜵甚するこずにより粟補、も
しくは郚分粟補した酵玠、又は䞊蚘酵玠を氎に䞍
溶性の担䜓に吞着もしくは包括固定化せしめた固
定化酵玠等を指し、本合成酵玠が菌株内酵玠であ
る堎合には培逊液から分離した生菌䜓を氎で掗浄
埌、アセトン、メタノヌル、゚タノヌル等有機溶
媒で凊理しお埗られる有機溶媒凊理菌䜓、生菌䜓
に磚砕、超音波凊理、现胞壁溶解酵玠凊理、又は
界面掻性剀凊理等の物理的、化孊的凊理を斜した
菌株、これら凊理菌株を氎、緩衝液等で抜出した
無现胞抜出液、及びその粟補酵玠、固定化酵玠、
もしくは固定化埮生物等をいう。 これら培逊物ずその凊理物を甚いお−アミノ
ペニシラン酞ず−−ハむドロキシプニ
ルヒダントむンずからアモキシシリンを補造す
る際の酵玠反応は、氎溶液䞭でも行われるが、収
率の面からメタノヌル、゚タノヌル、む゜プロパ
ノヌル、アセトン、メチルセル゜ルブ、ゞオキサ
ン、−ブタノヌル等の芪氎性有機溶媒を〜20
含む氎溶液䞭で行うこずがより望たしい。 酵玠反応を行う際の反応PHは4.0〜9.0、反応枩
床は20〜50℃で行われる。酵玠が氎に可溶性の堎
合䞊蚘酵玠反応は溶液䞭で行われるが、酵玠が氎
に䞍溶の堎合又は固定化酵玠の堎合には懞濁液䞭
又はカラム䞭に斌お反応が行われる。又埮生物を
培逊する際の培地もしくは培逊䞭に−−ハ
むドロキシプニルヒダントむンず−アミノ
ペニシラン酞を添加しお培逊すれば、埮生物の培
逊即ち酵玠の生産ずアモキシシリンの合成が同時
に行われるので䟿利である。 酵玠反応時間は基質の濃床、酵玠掻性、PH、借
雑䞍玔物の皮類、量、反応枩床等反応条件によ぀
お巊右されるが、芁はアモキシシリンの生成量が
最倧に達する時に反応を終了すればよく通垞〜
10時間で十分である。 本発明で甚いる−アミノペニシラン酞は遊離
の圢でもよく又ナトリりム塩、カリりム塩等塩の
圢でも䜿甚され、−−ハむドロキシプニ
ルヒダントむンは䜓、䜓、DL䜓のいずれ
でもよく、DL䜓が盎接䜿甚できるので工業的補
造法ずしおは極めお䟿利である。 このようにしお埗られる反応液からアモキシシ
リンを採取する方法ずしおは、公知の方法に準じ
お行えばよく、䟋えば未反応の−−ハむド
ロキシプニルヒダントむンは氎に溶けにくい
物質であるこずから、反応液を遠心分離するこず
の未反応の−−ハむドロキシプニルヒ
ダントむンの倧郚分及び菌株等の䞍溶性物質が陀
去される。 そこでこの液をHP−20等吞着暹脂カラムに通
しおアモキシシリンを吞着させ有機溶媒、氎など
の適圓な溶媒で溶出し、アモキシシリンを含む区
分を濃瞮し、適圓な芪氎性有機溶媒を加えお晶析
するこずによりアモキシシリンを採取するこずが
できる。 䞊述の劂く、本発明は−アミノペニシラン酞
ず−−ハむドロキシプニルヒダントむ
ンずから盎接アモキシシリンを補造する新しいア
モキシシリンの酵玠的補造法を提䟛するものであ
る。以䞋実斜䟋にお本発明を具䜓的に説明する。 実斜䟋  グルコヌス2.0dl、NH42SO40.5dl、
KH2PO40.1dl、K2HPO40.3dl、
MgSO4・7H2O0.05dl、FeSO4・7H2O1mg
dl、MnSO4・4H2O1mgdl、酵母゚キス1.0
dl、ペプトン1.0dl、DL−−メチルカプト
゚チルヒダントむン0.2dl、炭酞カルシりム
別殺菌を含む培地PH7.0を500ml容フラス
コに50ml宛入れ120℃で15分間殺菌した。 これにブむペン寒倩培地で30℃にお24時間培逊
したフラボバクテリりム・ヒダントむノフむルム
AL 11322FERM−P4819を癜金耳接皮し30℃
で20時間培逊した。この培逊液より菌䜓を遠心分
離により採取し、培逊液ず同量の生理食塩氎で
回掗浄し菌䜓を集めた。 この菌䜓を−アミノペニシラン酞0.5dl
及びDL−−−ハむドロキシプニルヒダ
ントむンdlを含む0.05Mdlリン酞緩衝液
終末PH7.0、mlにdlになるように添加
し、時間30℃に保持反応させた。反応埌、菌䜓
を遠心分離で陀去し、反応液䞭に生成したアモキ
シシリンをカチオン亀換暹脂デナポン瀟補の
「ZIPAX−SCX」䜿甚を甚いる高速液䜓クロマ
トグラフむヌで定量し、54.6Όmlのアモキシ
シリンを埗た。 尚、反応生成したアモキシシリンを−ブタノ
ヌル酢酞氎、−プロパノヌ
ル氎を甚いた薄局クロマトグラフむヌ
で比范したずころ暙準暙品のアモキシシリンず完
党に䞀臎した。たた、プロテりスミラビリスを甚
いるバむオアツセむ法によ぀お生成量を確認した
所ほが同䞀の結果が埗られた。 実斜䟋  グルコヌス2.0dl、NH42SO40.5dl、
KH2PO40.1dl、K2HPO40.3dl、
MgSO4・7H2O0.05dl、FeSO4・7H2O1mg
dl、MnSO4・4H2O1mgdl、酵母゚キス1.0
dl、ペプトン1.0dl、炭酞カルシりム別殺
菌を含む培地PH7.0を500ml容フラスコに50
ml入れ120℃、15分間殺菌した。 これにブむペン寒倩培地で30℃にお24時間培逊
したフラボバクテリりム・ヒダントむノフむルム
FERM−P4819を接皮し、30℃で16時間培逊し
た。培逊液に第衚に瀺す−眮換シダントむン
別殺菌したものを0.2dlになるように添加
し、曎に時間培逊を続けた。この培逊液より菌
株を遠心分離により採取し、培逊液ず同量の生理
食塩氎で回掗浄し菌株を集めた。 この菌株を−アミノペニシラン酞0.5dl
ずDL−−−ハむドロキシプニルヒダン
トむンdlを含む0.05Mリン酞緩衡液終末
PH7.0 mlにdlになるように添加し、
時間30℃に保持反応させた。反応埌菌䜓を遠心分
離で陀去し、反応液䞭に生成したアモキシシリン
を実斜䟋ず同様の方法で定量した。その結量を
第衚に瀺した。
[Table] (18) Oxidation of gluconic acid (Haynes method):
- (19) Deaminase reaction of phenylalanine (method of Ewing et al): - (20) Decarboxylase reaction (method of Mφller): Lysine - Ornithine - Arginine - (21) Arginine dihydrolase reaction (method of Stanier et al): NT (22) Degradability of casein: - (23) Degradability of DNA: - (24) Accumulation of poly-β-hydroxybutyrate: None (25) Auxotrophy: Yes (26) Degradability of cellulose: - (27) Salt tolerance: Does not grow in 3% salt (d) DNA GO content: 69.5% This bacterium is a Gram-negative bacillus, non-motile, aerobic,
It belongs to the genus Flavobacterium because it is catalase positive, oxidase positive, gradually decomposes sugar oxidatively to produce acid, and the color tone of the colony is buff to straw color. When searching for species, the known bacterial species described in the Bergey Manual 8th edition and this bacteria are motile, salt tolerant,
They do not match in important properties such as growth at 37℃, gelatin decomposition property, cellulose decomposition property, GO content of DNA, etc. Therefore, this bacterium is recognized as a new bacterial species.
It was named Flavobacterium hydantoinophilum. Some of the microorganisms used in the method of the present invention produce harmful enzymes, such as β-lactamase and amidase, which act on and convert the produced amoxicillin; It is desirable to breed mutant strains that do not. To produce the desired amoxicillin using microorganisms that produce amoxicillin synthase, these microorganisms are usually first cultured in a nutrient medium, and 6-aminopenicillanic acid and 5-(p-hydroxyphenyl)hydantoin may be reacted with 6-aminopenicillanic acid and 5-(p-
Add hydroxyphenyl) hydantoin,
Amoxicillin can also be produced by culturing microorganisms and carrying out an enzyme reaction simultaneously. The medium used for culturing microorganisms contains carbon sources, nitrogen sources,
A conventional nutrient medium containing inorganic ions and, if necessary, organic micronutrients such as vitamins, amino acids, and yeast extract is used. As the carbon source, carbohydrates such as glucose, sucrose, maltose, starch hydrolyzate, acetic acid, ethanol, etc. are used as appropriate. Further, as the nitrogen source, ammonia gas, aqueous ammonia, ammonium salt, peptone, meat extract, yeast extract, hydrolyzate of animal and plant proteins, etc. are used. As the inorganic ions, magnesium ions, potassium ions, sodium ions, calcium ions, iron ions, manganese ions, etc. are used as appropriate. Furthermore, in order to increase the activity of amoxicillin synthase, 5-substitutions shown in Table 1 such as DL-5-methylmercaptoethylhydantoin, DL-5-indolylmethylhydantoin, DL-5-(p-hydroxyphenyl)hydantoin, etc. It is desirable to add a hydantoin derivative to the medium as appropriate, and by adding 0.1 to 0.5 g/dl to the medium, the enzyme activity can be increased 4 to 5 times. The culture temperature may be within a temperature range suitable for the growth of microorganisms, and is 15 to 40°C, preferably 25 to 37°C. The culture time varies depending on the type of strain used, culture conditions, etc., but it is sufficient to terminate the culture when the enzymatic activity of the synthetic enzyme reaches its maximum, which is usually 16 to 48 hours.
The time is appropriate. The culture obtained in this way or its treated product is applied to the production reaction of amoxicillin, but the culture here refers to the culture solution itself, as well as viable bacterial bodies isolated from the culture solution, or bacteria from the culture solution. This refers to the culture fluid (supernatant) from which insoluble substances such as body fluids have been removed, and the treated product refers to the culture fluid that has been subjected to appropriate treatments to increase the enzymatic activity of amoxicillin synthase or maintain its activity stably for a long period of time. It refers to amoxicillin that has been processed to a state more suitable for manufacturing amoxicillin. For example, if the present synthetic enzyme is an extracellular enzyme, it can be purified from the above-mentioned culture solution by using known enzyme purification methods such as salting out, dialysis, adsorption/ion exchange chromatography, and gel filtration as appropriate, alone or in combination; It refers to a partially purified enzyme, or an immobilized enzyme obtained by adsorbing or comprehensively immobilizing the above enzyme on a water-insoluble carrier, and if the synthetic enzyme is an intra-strain enzyme, it refers to a live bacterial cell isolated from a culture solution. Organic solvent-treated bacterial cells obtained by washing with water and treatment with an organic solvent such as acetone, methanol, or ethanol, or physical treatment such as grinding, ultrasonication, cell wall lytic enzyme treatment, or surfactant treatment to viable bacterial cells. , chemically treated bacterial strains, cell-free extracts obtained by extracting these treated bacterial strains with water, buffer solutions, etc., and their purified enzymes, immobilized enzymes,
Or immobilized microorganisms, etc. The enzymatic reaction for producing amoxicillin from 6-aminopenicillanic acid and 5-(p-hydroxyphenyl)hydantoin using these cultures and their treated products is carried out in an aqueous solution, but from the viewpoint of yield. Hydrophilic organic solvents such as methanol, ethanol, isopropanol, acetone, methylcellosolve, dioxane, t-butanol, etc.
It is more desirable to carry out in an aqueous solution containing %. The enzyme reaction is carried out at a reaction pH of 4.0 to 9.0 and a reaction temperature of 20 to 50°C. When the enzyme is soluble in water, the enzymatic reaction is carried out in a solution, but when the enzyme is insoluble in water or is an immobilized enzyme, the reaction is carried out in suspension or in a column. In addition, if 5-(p-hydroxyphenyl)hydantoin and 6-aminopenicillanic acid are added to the medium or culture for culturing microorganisms, microbial culture, that is, enzyme production and amoxicillin synthesis, can occur at the same time. It is convenient because it can be done. Enzyme reaction time depends on reaction conditions such as substrate concentration, enzyme activity, pH, type and amount of contaminants, and reaction temperature, but in short, the reaction should be terminated when the maximum amount of amoxicillin produced is reached. Usually 1~
10 hours is enough. 6-Aminopenicillanic acid used in the present invention may be used in free form or in the form of sodium salt, potassium salt, etc., and 5-(p-hydroxyphenyl)hydantoin is in the D, L, and DL forms. Either method may be used, and since the DL form can be used directly, it is extremely convenient as an industrial production method. Amoxicillin can be collected from the reaction solution obtained in this way by following a known method.For example, unreacted 5-(p-hydroxyphenyl)hydantoin is a substance that is difficult to dissolve in water. Most of the unreacted 5-(p-hydroxyphenyl)hydantoin and insoluble substances such as bacterial strains are removed by centrifuging the reaction solution. Therefore, this solution is passed through an adsorption resin column such as HP-20 to adsorb amoxicillin and eluted with an appropriate solvent such as an organic solvent or water.The fraction containing amoxicillin is concentrated and crystallized by adding an appropriate hydrophilic organic solvent. Amoxicillin can be collected by doing this. As described above, the present invention provides a new enzymatic method for producing amoxicillin directly from 6-aminopenicillanic acid and 5-(p-hydroxyphenyl)hydantoin. The present invention will be specifically explained below with reference to Examples. Example 1 Glucose 2.0g/dl, (NH 4 ) 2 SO 4 0.5g/dl,
KH 2 PO 4 0.1g/dl, K 2 HPO 4 0.3g/dl,
MgSO 4・7H 2 O0.05g/dl, FeSO 4・7H 2 O1mg/
dl, MnSO 4・4H 2 O1mg/dl, yeast extract 1.0g/
1.0 g/dl of peptone, 0.2 g/dl of DL-5-methylcaptoethylhydantoin, and 50 ml of a medium (PH7.0) containing calcium carbonate (separately sterilized) was poured into a 500 ml flask and sterilized at 120°C for 15 minutes. . Flavobacterium hydantoinophilum was cultured on bouillon agar medium at 30°C for 24 hours.
One platinum loop of AL 11322FERM-P4819 was inoculated at 30°C.
The cells were cultured for 20 hours. Bacterial cells were collected from this culture solution by centrifugation, and diluted with the same amount of physiological saline as the culture solution.
The cells were washed twice and collected. 6-aminopenicillanic acid 0.5g/dl
and DL-5-(p-hydroxyphenyl)hydantoin was added to 0.05 M/dl phosphate buffer (final pH 7.0, 5 ml) containing 1 g/dl to give a concentration of 5 g/dl, and the mixture was heated at 30°C for 3 hours. Retention reaction was performed. After the reaction, the bacterial cells were removed by centrifugation, and the amoxicillin produced in the reaction solution was quantified by high performance liquid chromatography using a cation exchange resin (DuPont's "ZIPAX-SCX"), and it was found to be 54.6 Όg/ml. of amoxicillin was obtained. In addition, when the amoxicillin produced by the reaction was compared by thin layer chromatography using n-butanol:acetic acid:water = 4:1:2 and n-propanol:water = 7:3, it was completely compared with the standard amoxicillin. Agreed. Furthermore, when the production amount was confirmed by a bioassay method using Proteus mirabilis, almost the same results were obtained. Example 2 Glucose 2.0g/dl, (NH 4 ) 2 SO 4 0.5g/dl,
KH 2 PO 4 0.1g/dl, K 2 HPO 4 0.3g/dl,
MgSO 4・7H 2 O0.05g/dl, FeSO 4・7H 2 O1mg/
dl, MnSO 4・4H 2 O1mg/dl, yeast extract 1.0g/
50ml of medium (PH7.0) containing peptone 1.0g/dl and calcium carbonate (separately sterilized) in a 500ml flask.
ml and sterilized at 120°C for 15 minutes. Flavobacterium hydantoinophilum was cultured on bouillon agar medium at 30°C for 24 hours.
FERM-P4819 was inoculated and cultured at 30°C for 16 hours. 5-substituted cydantoin (separately sterilized) shown in Table 1 was added to the culture solution at a concentration of 0.2 g/dl, and the culture was continued for an additional 6 hours. Bacterial strains were collected from this culture solution by centrifugation, washed once with physiological saline in the same amount as the culture solution, and collected. 6-aminopenicillanic acid 0.5g/dl
and 0.05M phosphate buffer (terminated) containing DL-5-(p-hydroxyphenyl)hydantoin 1g/dl
PH7.0 5ml) to a concentration of 5g/dl,
The reaction was maintained at 30°C for a period of time. After the reaction, the bacterial cells were removed by centrifugation, and amoxicillin produced in the reaction solution was quantified in the same manner as in Example 1. The amount of coagulation is shown in Table 1.

【衚】【table】

【衚】 実斜䟋  実斜䟋に瀺した培地にブむペン寒倩䞊で30℃
にお24時間培逊したフラボバクテリりム・ヒダン
トむノフむラムFERM−P4819を接皮しお30℃で
16時間培逊した埌、培逊液にDL−−−ハむ
ドロキシプニルヒダントむン別殺菌を
0.4dlになるように添加し、時間培逊をし
た。この培逊液に無菌物に−アミノペニシラン
酞ずDL−−−ハむドロキシプニルヒダ
ントむンをそれぞれ0.5dl、1.0dlになる
ように添加し、曎に時間培逊を続けた。 この培逊液の菌株を遠心分離によ぀お陀去し、
培逊液䞊枅に生成したアモキシシリンを実斜䟋
ず同様の方法で定量した結果45Όmlであ぀
た。 実斜䟋  実斜䟋ず同様に調補したフラボバクテリり
ム・ヒダントむノフむラムFERM−P4819の菌䜓
をdlの濃床になるように0.5Mリン酞緩衡
液終末10mlに添加し、20KCの超音波にお
分間凊理した。この凊理物を遠心し䞊枅液を取埗
した。この䞊枅液mlに−アミノペニシラン酞
ずDL−−−ハむドロキシプニルヒダン
トむンをそれぞれ0.5dl、1.0dlになるよ
うに添加終末PH7.0し、30℃で時間反応さ
せた。この反応液䞊枅を枬定したずころ73.5ÎŒ
mlのアモキシシリンが生成しおいた。 実斜䟋  実斜䟋ず同様に調補したフラボバクテリり
ム・ヒダントむノフむラムFERM−P4819の菌䜓
を脱むオン氎mlに加えお懞濁し、氷冷した
のち、アクリルアミド750mgずメチレンビスアク
リルアミド45mgを加えお溶解させ、過硫酞アンモ
ニりム3.5mgおよび・N′−ゞメチルアミノプロ
ピオニトリルΌを加えお氷冷䞋に静眮し
た。時間埌、生成した菌䜓含有ゲルを50メツシ
ナの金網で裏ごしし、生理食塩氎で掗浄しゲル固
定化物を調補した。 この固定化物をDL−−−ハむドロキ
シプニルヒダントむンdl、−アミノ
ペニシラン酞0.5dlを含む0.05リン酞緩衡液
PH7.0mlに添加し、30℃、時間反応させ
た。この反応液䞊枅を枬定したずころ17.8Ό
mlのアモキシシリンが生成しおいた。 実斜䟋  実斜䟋の方法で調補したフラボバクテリり
ム・ヒダントむノフむラムFERM−P4819の菌䜓
を−アミノペニシラン酞0.5dl、DL−−
−ハむドロキシプニルヒダントむン1.0
dl、及び゚タノヌル〜20を含
む0.05Mリン酞緩衡液終末PH7.0、5.0mlに5.0
dlになるように添加し、30℃で時間酵玠反
応を行぀た。第衚に瀺すように゚タノヌルを添
加するこずによ぀おアモキシシリンの生成量は玄
倍に増倧した。
[Table] Example 3 The medium shown in Example 2 was grown on bouillon agar at 30°C.
Flavobacterium hydantoinophyllum FERM-P4819 cultured for 24 hours was inoculated at 30℃.
After culturing for 16 hours, add DL-5-p-(hydroxyphenyl)hydantoin (separately sterilized) to the culture solution.
It was added at a concentration of 0.4 g/dl and cultured for 4 hours. To this culture solution, 6-aminopenicillanic acid and DL-5-(p-hydroxyphenyl)hydantoin were added to a sterile solution at a concentration of 0.5 g/dl and 1.0 g/dl, respectively, and the culture was continued for an additional 3 hours. Ta. The bacterial strain in this culture solution is removed by centrifugation,
Example 1 Amoxicillin produced in the culture supernatant
The amount was determined in the same manner as above, and the result was 45 ÎŒg/ml. Example 4 Flavobacterium hydantoinophyllum FERM-P4819 cells prepared in the same manner as in Example 1 were added to a 0.5M phosphate buffer solution (final 10ml) to a concentration of 5g/dl. 5 with 20KC ultrasound
Processed for minutes. The treated product was centrifuged to obtain a supernatant. 6-aminopenicillanic acid and DL-(5-p-hydroxyphenyl)hydantoin were added to 5 ml of this supernatant at a concentration of 0.5 g/dl and 1.0 g/dl, respectively (final pH 7.0). The reaction was carried out at ℃ for 3 hours. When the supernatant of this reaction solution was measured, it was 73.5ÎŒ.
g/ml of amoxicillin was produced. Example 5 1 g of Flavobacterium hydantoinophyllum FERM-P4819 cells prepared in the same manner as in Example 1 was suspended in 4 ml of deionized water, cooled on ice, and then 750 mg of acrylamide and 45 mg of methylenebisacrylamide were added. 3.5 mg of ammonium persulfate and 8 ÎŒl of N·N'-dimethylaminopropionitrile were added, and the mixture was allowed to stand still under ice-cooling. After 1 hour, the resulting gel containing bacterial cells was strained through a 50-mesh wire mesh and washed with physiological saline to prepare an immobilized gel. 2 g of this immobilized product was added to 5 ml of 0.05 phosphate buffer solution (PH7.0) containing 1 g/dl of DL-5-(p-hydroxyphenyl)hydantoin and 0.5 g/dl of 6-aminopenicillanic acid. ℃ for 3 hours. When the supernatant of this reaction solution was measured, it was 17.8ÎŒg/
ml of amoxicillin was produced. Example 6 The cells of Flavobacterium hydantoinophyllum FERM-P4819 prepared by the method of Example 1 were treated with 0.5 g/dl of 6-aminopenicillanic acid and DL-5-
(p-hydroxyphenyl)hydantoin 1.0
g/dl, and 5.0 in 0.05 M phosphate buffer (final pH 7.0, 5.0 ml) containing ethanol 5-20% (V/V).
g/dl, and the enzymatic reaction was carried out at 30°C for 3 hours. As shown in Table 2, the amount of amoxicillin produced was approximately doubled by adding ethanol.

【衚】【table】

Claims (1)

【特蚱請求の範囲】[Claims]  フラボバクテリりム属に属し、−アミノペ
ニシラン酞ず−−ハむドロキシプニル
ヒダントむンずからアモキシシリンを合成する胜
力を有する埮生物の培逊物もしくはその凊理物の
存圚䞋に−アミノペニシラン酞ず−−ハ
むドロシキプニルヒダントむンずを反応させ
るこずを特城ずするアモキシシリンの補造方法。
1 Belongs to the genus Flavobacterium and contains 6-aminopenicillanic acid and 5-(p-hydroxyphenyl)
Amoxicillin, characterized in that 6-aminopenicillanic acid and 5-(p-hydroxyquiphenyl)hydantoin are reacted in the presence of a culture of a microorganism having the ability to synthesize amoxicillin from hydantoin or a treated product thereof. manufacturing method.
JP4257279A 1979-04-10 1979-04-10 Preparation of amoxicillin Granted JPS55135597A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP4257279A JPS55135597A (en) 1979-04-10 1979-04-10 Preparation of amoxicillin

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP4257279A JPS55135597A (en) 1979-04-10 1979-04-10 Preparation of amoxicillin

Publications (2)

Publication Number Publication Date
JPS55135597A JPS55135597A (en) 1980-10-22
JPS6231919B2 true JPS6231919B2 (en) 1987-07-10

Family

ID=12639773

Family Applications (1)

Application Number Title Priority Date Filing Date
JP4257279A Granted JPS55135597A (en) 1979-04-10 1979-04-10 Preparation of amoxicillin

Country Status (1)

Country Link
JP (1) JPS55135597A (en)

Also Published As

Publication number Publication date
JPS55135597A (en) 1980-10-22

Similar Documents

Publication Publication Date Title
US4072567A (en) Compound water-insoluble glucan and process for the production thereof
NZ225225A (en) Acid urease and its microbial production
US4391910A (en) Processes for producing thermophilic aspartase
JP3360291B2 (en) Method for Increasing Yield of γ-Cyclodextrin
JP3235904B2 (en) Thermostable mannose isomerase, method for producing the same, and method for producing mannose using the same
US5206162A (en) Process for making D-aminoacylase
US5130240A (en) Process for producing d-alpha-alanine and/or l-alpha-alanineamide by arthrobacter sp
JPS6231919B2 (en)
JPH0779696B2 (en) New preparation and its manufacturing method
JP3122990B2 (en) Process for producing O-methyl-L-tyrosine and L-3- (1-naphthyl) alanine
JPH01320991A (en) Production of d-homophenylalanines
US5252470A (en) D-amidase and process for producing D-α-alanine and/or L-α-alanineamide
US3144395A (en) Process for preparing 6-aminopenicillanic acid by bacillus megaterium
JPH05211868A (en) Method for producing alkaline protease
JPS6058068A (en) Novel amine dehydrogenase and oxidation of amine using it
JP3873512B2 (en) Method for producing D-3- (2-naphthyl) alanine
JP3027449B2 (en) Novel cyclomaltodextrinase, method for producing the same, and microorganism producing the enzyme
JP3272416B2 (en) Novel cyclodextrin glucanotransferase, method for producing the same, and method for producing cyclodextrin using the enzyme
JPH0614772A (en) New ester hydrolase a and its production
JPH0574353B2 (en)
JPH01228465A (en) Novel beta-agarase and production thereof
JP2899071B2 (en) Method for producing L-α-alanine
JPH0158957B2 (en)
JPH07184647A (en) α-L-fucosidase, its production method and Alcaligenes denitrificans sub sp. Denitrificans KSF-0901 strain
JPH0431672B2 (en)